IRIS UniCatt

Rocca, Bianca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.886
EU - Europa 4.696
AS - Asia 4.176
SA - Sud America 1.123
AF - Africa 147
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.756
SG - Singapore 2.027
DE - Germania 1.304
CN - Cina 1.068
BR - Brasile 921
SE - Svezia 792
IT - Italia 610
UA - Ucraina 516
FR - Francia 312
IE - Irlanda 288
VN - Vietnam 201
ID - Indonesia 193
GB - Regno Unito 189
FI - Finlandia 156
IN - India 151
RU - Federazione Russa 138
PL - Polonia 135
HK - Hong Kong 97
AR - Argentina 88
TR - Turchia 85
BD - Bangladesh 62
CA - Canada 56
IQ - Iraq 48
ES - Italia 47
MX - Messico 44
JP - Giappone 38
KR - Corea 36
BE - Belgio 35
NL - Olanda 35
ZA - Sudafrica 32
AT - Austria 30
AU - Australia 30
EC - Ecuador 27
IR - Iran 27
CZ - Repubblica Ceca 26
CI - Costa d'Avorio 25
CO - Colombia 24
VE - Venezuela 20
PK - Pakistan 19
ET - Etiopia 18
SA - Arabia Saudita 18
CH - Svizzera 16
PE - Perù 14
CL - Cile 13
EG - Egitto 11
IL - Israele 9
TN - Tunisia 9
UZ - Uzbekistan 9
GH - Ghana 8
JO - Giordania 8
KE - Kenya 8
MA - Marocco 8
PH - Filippine 8
DZ - Algeria 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
BG - Bulgaria 6
DO - Repubblica Dominicana 6
GR - Grecia 6
KW - Kuwait 6
LV - Lettonia 6
MK - Macedonia 6
NO - Norvegia 6
NP - Nepal 6
TW - Taiwan 6
HN - Honduras 5
KZ - Kazakistan 5
LT - Lituania 5
NG - Nigeria 5
RO - Romania 5
SN - Senegal 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
MN - Mongolia 4
MY - Malesia 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
AO - Angola 3
CR - Costa Rica 3
HU - Ungheria 3
JM - Giamaica 3
MT - Malta 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
BJ - Benin 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
SV - El Salvador 2
TJ - Tagikistan 2
Totale 15.042
Salva come PNG Salva come JPEG
Città #
Singapore 783
Chandler 658
Ashburn 628
Dublin 280
Jacksonville 258
Beijing 229
San Mateo 225
Jakarta 168
Wilmington 164
Nanjing 152
Rome 122
Warsaw 121
Woodbridge 120
Los Angeles 114
Ann Arbor 106
Hefei 101
Milan 100
New York 100
Houston 98
Munich 97
Boston 95
Lawrence 92
Hong Kong 90
Cattolica 88
Dearborn 71
Fairfield 70
Ho Chi Minh City 69
Moscow 66
Chicago 65
São Paulo 63
Nürnberg 59
Redwood City 59
Seattle 59
Princeton 53
Izmir 48
Frankfurt am Main 47
Dallas 45
Hanoi 45
Buffalo 38
Nanchang 38
Tianjin 34
Shenyang 33
Mountain View 32
Nuremberg 30
Kent 29
Brussels 27
Seoul 27
Boardman 26
Santa Clara 26
Turku 26
University Park 26
Abidjan 25
Redmond 25
Hangzhou 24
Hebei 24
Hyderabad 24
Zhengzhou 24
Bremen 23
Brno 22
Brooklyn 22
Helsinki 22
Kunming 22
London 21
Pune 21
Rio de Janeiro 21
Belo Horizonte 20
Brasília 20
Detroit 20
Shanghai 19
Tokyo 18
Bareggio 17
Cambridge 17
Wayne 17
Augusta 16
Dhaka 16
Federal 16
Guangzhou 16
Hounslow 16
Mexico 16
Tobarra 16
Vienna 16
Busto Arsizio 15
Fremont 15
Johannesburg 15
Leawood 15
Marseille 15
Phoenix 15
The Dalles 15
Denver 14
Norwalk 14
Washington 14
Atlanta 13
Baghdad 13
Porto Alegre 13
Amsterdam 12
Jiaxing 12
Stockholm 12
Cape Town 11
Curitiba 11
Manchester 11
Totale 7.051
Salva come PNG Salva come JPEG
Nome #
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 303
More, more, more: Reducing thrombosis in acute coronary syndromes beyond dual antiplatelet therapy-current data and future directions 271
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 247
Mean Platelet Volume, Platelet Distribution Width, and Platelet Count in Type 2 Diabetes Mellitus, Impaired Fasting Glucose, and Metabolic Syndrome: systematic review and meta-analysis 235
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. 178
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 177
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 176
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 175
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study 172
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 157
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 154
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 153
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 151
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 150
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13. A new prothrombotic mechanism associated with oxidative stress 146
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 144
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 143
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 140
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 136
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 135
Increased thromboxane biosynthesis in essential thrombocythemia. 134
Effect of fibrinogen concentration on the velocity of platelet aggregation. 132
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 131
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 120
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 114
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 113
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis 113
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 110
Aspirin: promise and resistance in the new millennium. 109
Drug insight: aspirin resistance- fact or fashion 109
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 109
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia 109
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 109
Determinants of the interindividual variability in response to antiplatelet drugs. 108
Another family with IGPS 107
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 107
Aspirin, stroke and drug-drug interactions 107
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. 105
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. 105
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 105
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 104
Fechtner syndrome: report of a third family and literature review 102
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 102
Homocysteinemia is inversely correlated with platelet count and inversely correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase 101
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 100
Type 2 Diabetes, Obesity, and Aspirin Responsiveness* 100
Eicosanoid biosynthesis and metabolism in myeloproliferative disorders 99
Platelet progenitors: the hidden drug target 98
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 98
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 98
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 97
Identifying determinants of variability to tailor aspirin therapy 97
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythemia 97
Farmaci antipiastinici 97
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 97
Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features 96
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 95
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 95
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment 94
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 93
The future of antiplatelet therapy in cardiovascular disease 92
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 92
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 91
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 91
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 90
Effect of ketorolac, ketoprofen and nefopam on platelet function 90
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects 89
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 89
Role of prostacyclin in the cardiovascular response to thromboxane A2 88
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 86
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 85
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease 85
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 83
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 83
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 83
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation 83
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 83
Cyclooxygenases and prostaglandins: shaping up the immune response 82
Aspirin and Other COX-1 Inhibitors 82
Familial autoimmune myasthenia gravis with different pathogenetic antibodies 82
Farmaci Antipiastrinici 82
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 82
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin 81
Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation 80
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 80
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 79
LACK OF AN ASSOCIATION BETWEEN INHERITED THROMBOPHILIC RISK FACTORS AND IDIOPATIC SUDDEN SENSORINEURAL HEARING LOSS IN ITALIAN PATIENTS 79
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 78
Antithrombotic therapy in diabetes: which, when, and for how long? 78
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. 77
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 76
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 76
Simply read: erythrocytes modulate platelet function. Should we rethink the way we give aspirin? 76
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. 76
Nonsteroidal antiinflammatory drugs: past, present and future 76
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 76
Measurement of Thromboxane Biosynthesis in Health and Disease 76
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 75
Pathophysiology of Thrombosis in Peripheral Artery Disease 75
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 75
Totale 11.041
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.197
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021601 0 0 0 0 0 54 115 27 140 50 181 34
2021/20221.145 157 93 13 73 86 32 32 187 44 33 175 220
2022/20232.133 313 301 176 241 175 237 75 172 257 43 95 48
2023/20241.357 43 348 42 179 80 132 97 29 28 69 136 174
2024/20252.510 61 54 196 89 199 67 36 155 416 214 556 467
2025/20263.699 1.124 208 530 733 1.056 48 0 0 0 0 0 0
Totale 15.236